Skip to main content
Premium Trial:

Request an Annual Quote

Lumora Raises $2.1M as It Seeks Entry into Clinical MDx Space

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK molecular diagnostics firm Lumora today announced it has raised £1.5 million ($2.1 million) in second-stage funding.

Catapult Venture Managers was the lead investor, contributing £1 million. Lumora's major shareholder Tate & Lyle Ventures contributed the balance in a follow-on investment, Lumora said.

The funds will be used to accelerate the company's entry in the clinical molecular diagnostics space with its lead technology platform, called Bioluminescent Assay in Real-time (BART), a reporter system for use with isothermal nucleic acid amplification technologies. BART is based on signaling technologies and "allows tests to be performed at a single temperature and without the need for expensive, optics, hence hardware is uniquely simple and low-cost," Lumora said in a statement.

The technology "represents an exciting new approach to bringing the advantages of molecular diagnostics to resource-limited settings," Lumora CEO Laurence Tisi said, adding that the company is collaborating with a "renowned" not-for-profit organization in HIV viral load monitoring.

BART has been used for food safety applications, and the company plans to move into the clinical molecular diagnostics market, which Lumora estimates is valued at $6 billion. Lumora's development programs are focused on applications including an integrated testing station for gastrointestinal infections and an HIV viral load monitoring system to support drug therapy in developing nations.

Lumora also announced Jim Reid has joined its board as a non-executive director. He has worked at Roche and Chiron.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.